Publication | Open Access

Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors

Medicinal ChemistryDrug TargetBenzimidazole DerivativesMedicineDrug DiscoveryNatural SciencesRational Drug DesignPdgfr Kinase InhibitorsAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyMolecular ModelingPharmaceutical ChemistryNovel Multi-target EgfrBiomolecular Engineering